Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94,179,674
-
Total 13F shares
-
104,559,713
-
Share change
-
+2,782,185
-
Total reported value
-
$3,007,383,972
-
Put/Call ratio
-
25%
-
Price per share
-
$28.76
-
Number of holders
-
220
-
Value change
-
+$75,026,428
-
Number of buys
-
127
-
Number of sells
-
102
Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q2 2025
As of 30 Jun 2025 Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) had 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 104,559,713 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., Driehaus Capital Management LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, FARALLON CAPITAL MANAGEMENT LLC, EcoR1 Capital, LLC, JANUS HENDERSON GROUP PLC, and STATE STREET CORP.
This table shows 220 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.